<qa>  What is the name of the study that will measure patient responses?Purpose: This study will measure patient responses and compare the efficacy of a double drug combination gemcitabine and trastuzumab with a triple drug combination gemcitabine, trastuzumab, and cisplatin in patients with metastatic breast cancer. Side effects will be carefully assessed in patients. 